Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
- PMID: 3306918
- DOI: 10.1126/science.3306918
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
Abstract
Tumor necrosis factor, or cachectin (TNF-alpha), a protein with a wide range of biological activities, is produced mainly by macrophages and may be important in inflammatory processes. The role of TNF-alpha in the pathogenesis of cerebral malaria was investigated in a murine model. Most CBA mice infected with Plasmodium berghei anka die between days 6 and 14 with acute neurological manifestations unrelated to the level of parasitemia, whereas mice of some other strains have malaria of the same severity that ends in death after 3 to 4 weeks without neurological manifestations. The activity of serum TNF-alpha was considerably increased in CBA/Ca mice with cerebral malaria but not in Plasmodium berghei-infected mice that did not develop this complication. One injection of rabbit antibody to TNF-alpha on day 4 or 7 fully protected infected mice from cerebral malaria without modifying the parasitemia, whereas immunoglobulins from normal rabbit had no effect. In mice with cerebral malaria, the cerebral vessels showed focal accumulations of packed macrophages often containing infected erythrocytes; this lesion was not seen in mice treated with antibody to TNF-alpha or in untreated mice without cerebral malaria. These findings indicate that TNF-alpha has an important role in the pathogenesis of cerebral malaria in this murine model and suggest that local accumulation and activation of macrophages may lead to the predominance of lesions in the central nervous system.
Similar articles
-
Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.J Exp Med. 1988 Oct 1;168(4):1499-504. doi: 10.1084/jem.168.4.1499. J Exp Med. 1988. PMID: 3049913 Free PMC article.
-
Essential role of tumor necrosis factor and other cytokines in the pathogenesis of cerebral malaria: experimental and clinical studies.Verh K Acad Geneeskd Belg. 1992;54(2):155-75. Verh K Acad Geneeskd Belg. 1992. PMID: 1357836
-
TNF and Plasmodium berghei ANKA-induced cerebral malaria.Immunol Lett. 1990 Aug;25(1-3):195-8. doi: 10.1016/0165-2478(90)90114-6. Immunol Lett. 1990. PMID: 2283149
-
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.Immunol Rev. 1989 Dec;112:49-70. doi: 10.1111/j.1600-065x.1989.tb00552.x. Immunol Rev. 1989. PMID: 2575074 Review.
-
Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology.Int Arch Allergy Appl Immunol. 1989;88(1-2):34-9. doi: 10.1159/000234744. Int Arch Allergy Appl Immunol. 1989. PMID: 2651318 Review.
Cited by
-
An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria.PLoS One. 2012;7(2):e31012. doi: 10.1371/journal.pone.0031012. Epub 2012 Feb 21. PLoS One. 2012. PMID: 22363534 Free PMC article.
-
Where are we in the quest for vaccines for malaria?Drugs. 1991 Jan;41(1):1-10. doi: 10.2165/00003495-199141010-00001. Drugs. 1991. PMID: 1706981 Review. No abstract available.
-
Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.J Virol. 1989 Oct;63(10):4404-8. doi: 10.1128/JVI.63.10.4404-4408.1989. J Virol. 1989. PMID: 2789293 Free PMC article.
-
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.J Exp Med. 1987 Nov 1;166(5):1280-9. doi: 10.1084/jem.166.5.1280. J Exp Med. 1987. PMID: 3316469 Free PMC article.
-
Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats.Clin Exp Immunol. 1992 Nov;90(2):312-8. doi: 10.1111/j.1365-2249.1992.tb07948.x. Clin Exp Immunol. 1992. PMID: 1385027 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical